Biopharma
Biopharma, short for biopharmaceutical, describes companies and products that develop therapies derived from biological sources such as proteins, antibodies, and cells, rather than from purely chemical synthesis. The sector spans drug discovery, manufacturing, and commercialization of complex biologic medicines.
What is biopharma?
Biopharma, short for biopharmaceutical, refers to the companies and products centered on therapies derived from biological sources, such as proteins, antibodies, and cells, rather than from purely chemical synthesis. The term captures both the firms working in this space and the complex biologic medicines they create.
The sector covers the full arc of bringing such therapies forward, from drug discovery and development through manufacturing and commercialization. It is closely intertwined with biologics, the products at the heart of the field.
Why does biopharma matter?
Biopharma plays a significant role in advancing treatments for conditions that have been difficult to address with traditional small-molecule drugs. Its products often target disease mechanisms in precise ways, expanding the therapeutic options available to patients.
Because biologic medicines are complex to develop and produce, the sector involves substantial investment in research, specialized manufacturing, and regulatory navigation. These dynamics shape both the pace of innovation and the cost of the resulting therapies.
- what is biopharma
- biopharma meaning
- biopharmaceutical definition
- biopharma vs pharma
- biopharma industry
- biopharmaceutical companies